MedPath

宁波双成药业有限公司

Ownership
-
Established
2014-09-02
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Pregabalin Capsules

Product Name
普瑞巴林胶囊
Approval Number
国药准字H20243330
Approval Date
Mar 12, 2024
NMPA

Pregabalin Capsules

Product Name
普瑞巴林胶囊
Approval Number
国药准字H20243331
Approval Date
Mar 12, 2024
NMPA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath